Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals

Mayank Handa; Obaid Afzal; Sarwar Beg; Sachin Nashik Sanap; Ravinder K. Kaundal; Rahul K. Verma; Awanish Mishra; Rahul Shukla

doi:10.1016/j.drudis.2023.103555

Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals

Mayank Handa, Obaid Afzal, Sarwar Beg, Sachin Nashik Sanap, Ravinder K. Kaundal, Rahul K. Verma, Awanish Mishra, Rahul Shukla

Pharmaceutical Chemistry

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Tailoring drug products to personalized medicines poses challenges for conventional dosage forms. The prominent reason is the restricted availability of flexible dosage strengths in the market. Inappropriate dosage strengths lead to adverse drug reactions or compromised therapeutic effects. The situation worsens when the drug has a narrow therapeutic window. To overcome these challenges, data-enriched edible pharmaceuticals (DEEP) are novel concepts for designing solid oral products. DEEP have individualized doses and information embedded in quick response (QR) code form. When data are presented in a QR code, the information is printed with edible ink that contains the drug in tailored doses required for the patients.

Original language	English
Article number	103555
Journal	Drug Discovery Today
Volume	28
Issue number	5
DOIs	https://doi.org/10.1016/j.drudis.2023.103555
State	Published - May 2023

Keywords

digital dosage
drug delivery
pediatric
personalized medicine
quick response

Access to Document

10.1016/j.drudis.2023.103555

Cite this

@article{6b1813804f474b7da9aae85f1344ea3e,

title = "Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals",

abstract = "Tailoring drug products to personalized medicines poses challenges for conventional dosage forms. The prominent reason is the restricted availability of flexible dosage strengths in the market. Inappropriate dosage strengths lead to adverse drug reactions or compromised therapeutic effects. The situation worsens when the drug has a narrow therapeutic window. To overcome these challenges, data-enriched edible pharmaceuticals (DEEP) are novel concepts for designing solid oral products. DEEP have individualized doses and information embedded in quick response (QR) code form. When data are presented in a QR code, the information is printed with edible ink that contains the drug in tailored doses required for the patients.",

keywords = "digital dosage, drug delivery, pediatric, personalized medicine, quick response",

author = "Mayank Handa and Obaid Afzal and Sarwar Beg and \{Nashik Sanap\}, Sachin and Kaundal, \{Ravinder K.\} and Verma, \{Rahul K.\} and Awanish Mishra and Rahul Shukla",

note = "Publisher Copyright: {\textcopyright} 2023 Elsevier Ltd",

year = "2023",

month = may,

doi = "10.1016/j.drudis.2023.103555",

language = "English",

volume = "28",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals

AU - Handa, Mayank

AU - Afzal, Obaid

AU - Beg, Sarwar

AU - Nashik Sanap, Sachin

AU - Kaundal, Ravinder K.

AU - Verma, Rahul K.

AU - Mishra, Awanish

AU - Shukla, Rahul

PY - 2023/5

Y1 - 2023/5

N2 - Tailoring drug products to personalized medicines poses challenges for conventional dosage forms. The prominent reason is the restricted availability of flexible dosage strengths in the market. Inappropriate dosage strengths lead to adverse drug reactions or compromised therapeutic effects. The situation worsens when the drug has a narrow therapeutic window. To overcome these challenges, data-enriched edible pharmaceuticals (DEEP) are novel concepts for designing solid oral products. DEEP have individualized doses and information embedded in quick response (QR) code form. When data are presented in a QR code, the information is printed with edible ink that contains the drug in tailored doses required for the patients.

AB - Tailoring drug products to personalized medicines poses challenges for conventional dosage forms. The prominent reason is the restricted availability of flexible dosage strengths in the market. Inappropriate dosage strengths lead to adverse drug reactions or compromised therapeutic effects. The situation worsens when the drug has a narrow therapeutic window. To overcome these challenges, data-enriched edible pharmaceuticals (DEEP) are novel concepts for designing solid oral products. DEEP have individualized doses and information embedded in quick response (QR) code form. When data are presented in a QR code, the information is printed with edible ink that contains the drug in tailored doses required for the patients.

KW - digital dosage

KW - drug delivery

KW - pediatric

KW - personalized medicine

KW - quick response

UR - http://www.scopus.com/inward/record.url?scp=85150920069&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2023.103555

DO - 10.1016/j.drudis.2023.103555

M3 - Review article

C2 - 36931386

AN - SCOPUS:85150920069

SN - 1359-6446

VL - 28

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 5

M1 - 103555

ER -

Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this